Elise F. Nassif

Oncology
1515 Holcombe Blvd
Houston, TX 77030

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

LPAR4 mediates resistance to interferon-induced stress in soft tissue sarcoma.

LPAR4 mediates resistance to interferon-induced stress in soft tissue sarcoma.

Journal: Science advances
Published: June 12, 2026

Spatially-Resolved Multiomic Atlas of Leiomyosarcoma Identifies Two Clinically Relevant Epigenetically-Driven Cell States.

Spatially-Resolved Multiomic Atlas of Leiomyosarcoma Identifies Two Clinically Relevant Epigenetically-Driven Cell States.

Journal: bioRxiv : the preprint server for biology
Published: June 05, 2026

Editorial: Precision therapeutics in rare cancers: targeting tumor microenvironment and biomarker-driven approaches.

Editorial: Precision therapeutics in rare cancers: targeting tumor microenvironment and biomarker-driven approaches.

Journal: Frontiers in immunology
Published: May 18, 2026

Spatially-resolved single cell atlas of liposarcoma reveals lineage hierarchies, immune niches, and regulatory circuits.

Spatially-resolved single cell atlas of liposarcoma reveals lineage hierarchies, immune niches, and regulatory circuits.

Journal: bioRxiv : the preprint server for biology
Published: April 03, 2026

Ectopic ACTH syndrome in an adult with metastatic Ewing sarcoma.

Ectopic ACTH syndrome in an adult with metastatic Ewing sarcoma.

Journal: JCEM case reports
Published: January 24, 2026

First-Line Chemotherapy Regimens for Advanced and Metastatic Leiomyosarcoma: Doxorubicin vs. Gemcitabine-A Systematic Review.

First-Line Chemotherapy Regimens for Advanced and Metastatic Leiomyosarcoma: Doxorubicin vs. Gemcitabine-A Systematic Review.

Journal: Cancers
Published: December 16, 2025

Health-Related Quality of Life in the Era of Immune Checkpoint Blockade: What Do Patient-Reported Outcomes Reveal?

Health-Related Quality of Life in the Era of Immune Checkpoint Blockade: What Do Patient-Reported Outcomes Reveal?

Journal: Cancers
Published: November 16, 2025

High dietary fiber is associated with improved outcomes in patients with melanoma and sarcoma treated with immunotherapy regardless of gut microbiome dysbiosis and social vulnerability.

High dietary fiber is associated with improved outcomes in patients with melanoma and sarcoma treated with immunotherapy regardless of gut microbiome dysbiosis and social vulnerability.

Journal: Cancer
Published: August 21, 2025

Case Report: Complete response to the concurrent neoadjuvant radiation therapy and pembrolizumab in a locally recurrent, chemotherapy-refractory undifferentiated pleomorphic sarcoma of bone.

Case Report: Complete response to the concurrent neoadjuvant radiation therapy and pembrolizumab in a locally recurrent, chemotherapy-refractory undifferentiated pleomorphic sarcoma of bone.

Journal: Frontiers in oncology
Published: June 12, 2025

Sarcoma: Cardiovascular and Oncologic Considerations: JACC: CardioOncology State-of-the-Art Review.

Sarcoma: Cardiovascular and Oncologic Considerations: JACC: CardioOncology State-of-the-Art Review.

Journal: JACC. CardioOncology
Published: May 28, 2025

Poly(adenosine diphosphate ribose) polymerase inhibition in isocitrate dehydrogenase 1 and 2-mutant tumors: Bridging science with the clinic.

Poly(adenosine diphosphate ribose) polymerase inhibition in isocitrate dehydrogenase 1 and 2-mutant tumors: Bridging science with the clinic.

Journal: Cancer
Published: May 05, 2025

Hyalinization-based pathologic response and immune infiltration following neoadjuvant radiotherapy with or without immune-checkpoint blockade in localized undifferentiated pleomorphic sarcoma.

Hyalinization-based pathologic response and immune infiltration following neoadjuvant radiotherapy with or without immune-checkpoint blockade in localized undifferentiated pleomorphic sarcoma.

Journal: ESMO open
Published: February 18, 2025
Showing 1-12 of 21

Last Updated: 09/26/2026